Tango Therapeutics Inc. (NASDAQ:TNGX) price closed higher on Friday, September 15, jumping 3.28% above its previous close.
A look at the daily price movement shows that the last close reads $8.24, with intraday deals fluctuated between $8.07 and $8.53. Taking into account the 52-week price action we note that the stock hit a 52-week high of $9.39 and 52-week low of $2.47. The stock added 24.42% on its value in the past month.
Revisions to the company’s EPS highlights a short term direction of a stock’s price movement, which in the last 7 days came up with no upward and no downward reviews. On the technical perspective front, indicators give TNGX a short term outlook of 100% Buy on average. Looking at the stock’s medium term indicators we note that it is averaging as a 100% Buy, while an average of long term indicators are currently assigning the stock as 50% Buy.
Here is a look at the average analyst rating for the stock as represented on a scale of 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock is strong buy or strong sell respectively. Specifically, 5 analysts have assigned TNGX a recommendation rating as follows: 0 rate it as a Hold; 4 advise Buy while 1 analyst(s) assign an Overweight rating. 0 analyst(s) have tagged the Tango Therapeutics Inc. (TNGX) stock as Underweight, with 0 recommending Sell. In general, analysts have rated the stock Buy, a scenario likely to bolster investors out for an opportunity to add to their holdings of the company’s shares.
The overview shows that TNGX’s price is at present 16.57% off the SMA20 and 58.69% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 69.23, with weekly volatility standing at 7.61%. The indicator jumps to 8.28% when calculated based on the past 30 days. Tango Therapeutics Inc. (NASDAQ:TNGX)’s beta value is holding at 1.40, while the average true range (ATR) indicator is currently reading 0.62. Considering analysts have assigned the stock a price target range of $16.00-$20.00 as the low and high respectively, we find the trailing 12-month average consensus price target to be $17.60. Based on this estimate, we see that current price is roughly -88.01% off the estimated low and -135.02% off the forecast high. Investors will no doubt be excited to see the share price fall to $18.00, which is the median consensus price, and at that level TNGX would be -111.52% from current price.
An analysis of the Tango Therapeutics Inc. (NASDAQ:TNGX) stock in terms of its daily trading volume indicates that the 3-month average is 1.71 million. However, this figure increases on the past 10-day timeline to an average of 0.81 million.
Current records show that the company has 88.36M in outstanding shares. The insiders’ percentage holdings are 15.32% of outstanding shares while the percentage share held by institutions stands at 77.60%. The stats also highlight that short interest as of Aug 30, 2023, stood at 2.58 million shares, which puts the short ratio at the time at 0.63. From this we can glean that short interest is 2.54% of company’s current outstanding shares. Notably, we see that shares short in August rose slightly given the previous month’s figure stood at 1.63 million. But the 17.38% upside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.